tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Nuchev Limited Issues New Shares, Affirms Regulatory Compliance

Story Highlights
Nuchev Limited Issues New Shares, Affirms Regulatory Compliance

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Nuchev Pty Ltd ( (AU:NUC) ) has issued an update.

Nuchev Limited has issued 8,749,000 fully paid ordinary shares without disclosure to investors, in compliance with the Corporations Act 2001. The company confirms adherence to its reporting and disclosure obligations, with no excluded information requiring disclosure. This move reflects Nuchev’s ongoing commitment to transparency and regulatory compliance, potentially impacting its market operations and stakeholder confidence.

The most recent analyst rating on (AU:NUC) stock is a Hold with a A$0.14 price target. To see the full list of analyst forecasts on Nuchev Pty Ltd stock, see the AU:NUC Stock Forecast page.

More about Nuchev Pty Ltd

Nuchev is an Australian-based nutritional and wellness business. The company offers products under brands such as Oli6®, Bio Practica, and Medicine Tree, as well as several globally recognized European brands sold under exclusive license in Australia and New Zealand by bWellness. Oli6® is available in key Australian pharmacy and grocery channels, China, and other international markets through online and general trade retail. Nuchev is dedicated to sourcing world-class ingredients and manufacturing in industry-leading Australian facilities to ensure high-quality products for consumers.

Average Trading Volume: 32,723

Technical Sentiment Signal: Buy

Current Market Cap: A$23.47M

See more insights into NUC stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1